Nurix Therapeutics (NRIX) Cash from Financing Activities (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Cash from Financing Activities of $66,000 in fiscal Q2 2026 (quarter ended May 31, 2026), compared with $6,000 a year earlier and down 99.7% from the prior quarter.
Nurix Therapeutics (NRIX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
On a TTM basis, Nurix Therapeutics' Cash from Financing Activities came in at $257.2 million as of May 31, 2026, up 3.8% year-over-year; for FY2025 (ended Nov 30, 2025), it came in at $238.64 million, down 50.9% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- Across earlier fiscal years, Cash from Financing Activities came in at $485.67 million in FY2024, $3.22 million in FY2023 (-97.3%), $117.19 million in FY2022 (-23.8%) and $153.88 million in FY2021 (-54.6%).
- Quarterly Cash from Financing Activities has ranged from -$135,000 in fiscal Q4 2022 to $237.75 million in fiscal Q2 2024 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in 1 of the last four quarters, with an average decline of 47.3%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 17.7% in fiscal Q4 2025, against a decline of 100.0% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $19.98 million (Q1 2026), $236.01 million (Q4 2025) and $1.16 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | 66,000.00 |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 66,000.00 |
| Feb 28, 2026 | 19.98 Mn |
| Nov 30, 2025 | 236.01 Mn |
| Aug 31, 2025 | 1.16 Mn |
| May 31, 2025 | 6,000.00 |
| Feb 28, 2025 | 1.47 Mn |
| Nov 30, 2024 | 200.52 Mn |
| Aug 31, 2024 | 45.77 Mn |
| May 31, 2024 | 237.75 Mn |
| Feb 29, 2024 | 1.62 Mn |
| Nov 30, 2023 | 7,000.00 |
| Aug 31, 2023 | 1.70 Mn |
| May 31, 2023 | 25,000.00 |
| Feb 28, 2023 | 1.48 Mn |
| Nov 30, 2022 | -135,000.00 |
| Aug 31, 2022 | 115.41 Mn |
| May 31, 2022 | 432,000.00 |
| Feb 28, 2022 | 1.49 Mn |
| Nov 30, 2021 | 500,000.00 |
| Aug 31, 2021 | 1.55 Mn |
Nurix Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();